Hearing entitled “The Cost of Being a Public Company in Light of Sarbanes-Oxley and the Federalization of Corporate Governance”
Tuesday, July 18, 2017 10:00 AM in 2128 Rayburn HOB Capital Markets, Securities, and Investment
Mr. John Blake, Senior Vice President of Finance, aTyr Pharma, Inc. (TTF)
Mr. Thomas Quaadman, Executive Vice President, Center for Capital Market Competitiveness, U.S. Chamber of Commerce (TTF)
Professor J. Robert Brown, Jr., Lawrence W. Treece Professor of Corporate Governance, Director, Corporate and Commercial Law Program, University of Denver Sturm College of Law (TTF)